Prediabetic States, Subclinical Atheromatosis, and Oxidative Stress in Renal Transplant Patients

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2148-2150

  Osorio, J M ^a   Ferreyra, C ^a   Perez A ^a   Moreno, J M ^a   Osuna, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; CYCLOSPORIN; DACLIZUMAB; GLUCOSE; MALONALDEHYDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ATHEROGENESIS; ATHEROMATOSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INTIMA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA; ULTRASOUND;

ADULT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; PREDIABETIC STATE; RENAL DIALYSIS; TIME FACTORS;

EID: 68949202250     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.002     Document Type: Article

References (17)

1. Kasiske B.L. Cardiovascular disease after renal transplantation. Semin Nephrol 20 (2000) 176
2. Kasiske B.L. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 72 6 suppl (2001) 55
3. Davison J.A., and Wilkinson A. International Expert Panel on New-Onset Diabetes After Transplantation: New-Onset Diabetes After ransplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 27 (2004) 805
4. Cosio F.G., Hickson L.J., Giffin M.D., et al. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 8 (2008) 593
5. Anonymous. Standards of Medical Care in Diabetes-2008. American Diabetes Association. Diabetes Care 31 suppl 1 (2008) S12
6. Delgado P., Diaz J.M., Osorio J.M., et al. Unmasking glucose metabolism alterations in stable renal transplant recipients: a multicenter study. Clin J Am Soc Nephrol 3 (2008) 808
7. Alvarez A., Fernandez J., Porrini E., et al. Carotid atheromatosis in nondiabetic renal transplant patients: the role of prediabetic glucose homeostasis alterations. Transplantation 84 (2007) 870
8. Cofan F., Arias M., Nuñez I., et al. Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation. Transplant Proc 39 (2007) 2236
9. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381
10. Steinerová A., Racek J., Stozický F., et al. Antibodies against oxidized LDL-theory and clinical use. Physiol Res 50 (2001) 131
11. Bennefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Nutr Metab Care 5 (2002) 561
12. Moreno J.M., Ruiz M.C., Ruiz I., et al. Modulation of oxidative status in stable renal transplantation. Transplant Proc 37 (2005) 1428
13. Ruiz M.C., Medina A., Moreno J.M., et al. Relationship between oxidative stress parameters and atherosclerotic signs in the carotid artery of stable renal transplant patients. Transplant Proc 37 (2005) 3796
14. Montuschi P., Barnes P., and Roberts II L.J. Insights into oxidative stress: the isoprostanes. Curr Med Chem 14 (2007) 703
15. Boratynska M., Boratinsky J., Klinger M., et al. Lipid peroxidation and cytokines in chronic allograft failure: influence of nonimmunological risk factors. Transplant Proc 32 (2000) 1384
16. Menon V., Ram M., Dorn J., et al. Oxidative stress and glucose levels in a population-based sample. Diabet Med 21 (2004) 1346
17. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease?. The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816